glp-1 resources How Do Injections Help with Medical Weight Loss? Indications for GLP-1/GIP RA Summary

GLP-1 increases insulin release, decreases glucagon, slows stomach emptying, and enhances satiety to control blood sugar

Numerous studies have demonstrated that for every 10% increase in body mass index (BMI), the risk of developing OSAS increases by nearly six-fold (7, 8)

doi: 10.1016/S0140-6736(18)32260-8

Dry mouth during semaglutide treatment may result from indirect factors such as reduced fluid intake due to appetite suppression, dehydration from gastrointestinal side effects, or concurrent medications that cause xerostomia rather than a direct effect of semaglutide itself

In addition to effects on weight and blood glucose control, early laboratory studies in mice suggest that GLP-1 RAs might work through additional biological mechanisms ( 10 , 11 )